Efficacy of olanzapine for prophylaxis of delayed chemotherapy-induced nausea and vomiting in patients with breast cancer receiving dose-dense AC with a steroid-sparing regimen: a single-center pilot study

Related articles

1. Fosnetupitant for long-delayed chemotherapy-induced nausea and vomiting in oxaliplatin-based regimens: A prospective observational study (LODEC-N)

   This article has 10 authors:

   1. Yohei Iimura
   2. Hirotoshi Iihara
   3. Takeshi Aoyama
   4. Toshinobu Hayashi
   5. Masaaki Ishibashi
   6. Chieko Sasuga
   7. Naoki Furukawa
   8. Eri Anzai
   9. Yuki Ijichi
   10. Seiichiro Kuroda

2. Predictive Patient Characteristics for Chemotherapy-Induced Nausea and Vomiting in Solid Organ Cancers: An Observational Study from a Tertiary Care Setting

   This article has 5 authors:

   1. Mayank Kapoor
   2. Deepak Sundriyal
   3. Yogesh Bahurupi
   4. Sweety Gupta
   5. Amit Sehrawat

3. Clinical Impact of Olaparib Dose Reduction Compared with Bevacizumab and Standard-Dose Olaparib in Platinum-Sensitive Recurrent Ovarian Cancer

   This article has 13 authors:

   1. Shunsuke Tatsuki
   2. Tadahiro Shoji
   3. Ami Jo
   4. Nanako Jonai
   5. Yohei Chiba
   6. Sho Sato
   7. Eriko Takatori
   8. Yoshitaka Kaido
   9. Takayuki Nagasawa
   10. Masahiro Kagabu
   11. Takeshi Aida
   12. Fumiharu Miura
   13. Tsukasa Baba